
Albireo Pharma ALBO
Quarterly report 2022-Q3
added 11-08-2022
Albireo Pharma Depreciation & Amortization 2011-2026 | ALBO
Annual Depreciation & Amortization Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 274 K | 192 K | 127 K | 45 K | 35 K | 14 K | 15 K | 603 K | 641 K | 725 K | 938 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 938 K | 14 K | 328 K |
Quarterly Depreciation & Amortization Albireo Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 322 K | 198 K | 114 K | - | 167 K | 75 K | 37 K | - | 119 K | 77 K | 39 K | - | 89 K | 50 K | 11 K | - | 33 K | 22 K | 53 K | - | 23 K | 13 K | 5 K | - | 11 K | 7 K | 4 K | 30 K | 211 K | 164 K | - | 102 K | 462 K | 310 K | 102 K | 156 K | 484 K | 326 K | 156 K | 167 K | 555 K | 382 K | 167 K | 194 K | 732 K | 502 K | 194 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 732 K | 4 K | 172 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Rezolute
RZLT
|
31 K | $ 3.37 | 5.82 % | $ 256 M | ||
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
58 K | - | 5.93 % | $ 314 M | ||
|
Akero Therapeutics
AKRO
|
18 K | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
2.49 M | - | 0.23 % | $ 488 M | ||
|
I-Mab
IMAB
|
23.9 M | - | - | $ 866 M | ||
|
Aileron Therapeutics
ALRN
|
63 K | - | 10.36 % | $ 9.8 M | ||
|
Cabaletta Bio
CABA
|
1.65 M | $ 2.85 | 2.34 % | $ 286 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.51 M | - | - | $ 26.5 M | ||
|
Sana Biotechnology
SANA
|
12.8 M | $ 3.13 | 0.97 % | $ 793 M | ||
|
AgeX Therapeutics
AGE
|
100 K | - | -10.17 % | $ 12.2 K | ||
|
Aptinyx
APTX
|
122 K | - | -39.0 % | $ 4.57 M | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Equillium
EQ
|
116 K | $ 2.11 | 2.43 % | $ 121 M | ||
|
Adverum Biotechnologies
ADVM
|
3.65 M | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
369 K | - | -9.65 % | $ 45.9 M | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
7.55 M | $ 1.34 | 0.75 % | $ 342 M | ||
|
Atreca
BCEL
|
5.46 M | - | -11.76 % | $ 5.79 M | ||
|
BeiGene, Ltd.
BGNE
|
142 M | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
Cara Therapeutics
CARA
|
259 K | - | -3.03 % | $ 260 M | ||
|
ChemoCentryx
CCXI
|
3.14 M | - | - | $ 3.74 B | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Avid Bioservices
CDMO
|
11.1 M | - | - | $ 789 M | ||
|
CRISPR Therapeutics AG
CRSP
|
19.5 M | $ 48.18 | 2.32 % | $ 4.33 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
363 K | $ 4.49 | -0.99 % | $ 860 M | ||
|
AIkido Pharma
AIKI
|
105 K | - | 1.93 % | $ 17.4 M | ||
|
Allakos
ALLK
|
6.14 M | - | - | $ 28.6 M | ||
|
Seer
SEER
|
5.6 M | $ 1.72 | -0.29 % | $ 110 M | ||
|
Brickell Biotech
BBI
|
41 K | - | -5.38 % | $ 6.06 M | ||
|
Eli Lilly and Company
LLY
|
2 B | $ 905.44 | -1.19 % | $ 812 B | ||
|
Allena Pharmaceuticals
ALNA
|
363 K | - | 3.16 % | $ 1.9 M | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K |